STING1 and gastric cancer: Eventually, WEE1 inhibition triggers gastric cancer cell-intrinsic innate immunity through the activation of the cGAS/STING pathway, and thus, potentiates the anticancer effect of ICB therapy in MUS81 deficient gastric cancer cells.